Acadian Asset Management’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,236
Closed -$7K 1697
2023
Q3
$7K Sell
2,236
-3,201
-59% -$11.5K ﹤0.01% 1605
2023
Q2
$22K Sell
5,437
-6,161
-53% -$31.9K ﹤0.01% 1639
2023
Q1
$99K Hold
11,598
﹤0.01% 1397
2022
Q4
$151K Hold
11,598
﹤0.01% 1350
2022
Q3
$198K Hold
11,598
﹤0.01% 1215
2022
Q2
$127K Hold
11,598
﹤0.01% 1304
2022
Q1
$256K Sell
11,598
-892
-7% -$21.5K ﹤0.01% 1154
2021
Q4
$428K Buy
+12,490
New +$590K ﹤0.01% 1050
2021
Q1
Sell
-2,573
Closed -$157K 2108
2020
Q4
$157K Buy
2,573
+606
+31% +$41.3K ﹤0.01% 1630
2020
Q3
$239K Sell
1,967
-5,688
-74% -$650K ﹤0.01% 1385
2020
Q2
$905K Buy
7,655
+2,266
+42% +$189K ﹤0.01% 995
2020
Q1
$285K Buy
5,389
+346
+7% +$24.7K ﹤0.01% 1110
2019
Q4
$274K Buy
+5,043
New +$471K ﹤0.01% 1217

Other funds holding CYCN